MLR-1023: Phase IIa data

A double-blind, U.S. and South Korean Phase IIa trial in 130 Type II diabetics showed that oral MLR-1023 for 4

Read the full 201 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE